5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer

PVI 5FU gives increased response rates and reduced toxicity when compared to bolus 5FU (J Clin Oncol 1989, 425–432). PVI 5FU administration was reported to give highly variable (>1000-fold) plasma 5FU concentrations at steady state (FU Css) which correlated with toxicity (Ann Oncol 1996, 47–53);...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jodrell, D I, Stewart, M, Aird, R, Knowles, G, Bowman, A, Wall, L, Cummings, J, McLean, C
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2001
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363784/
https://ncbi.nlm.nih.gov/pubmed/11237378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1664
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires